CXCL8 and infection: Dahan et al. [35] and Dalmasso et al. [36] showed that the use of Streptococcus boulardii as a dietary supplement in humans inhibits the release of pro-inflammatory cytokines such as IL-8, IL-6, and TNF-α in response to infection.